Oximio attains WDA licence from Medicines & Healthcare Products Regulatory Agency

Oximio is delighted to announce a significant expansion of its capabilities in the UK by attaining a Wholesale Distribution Authorisation (WDA) licence from the Medicines and Healthcare Products Regulatory Agency (MHRA).

The WDA licence assigns Oximio the authorisation to procure, supply, store and distribute human medicinal products across all temperature regimes.

“This is a major milestone for Oximio” says Chief Commercial Officer, Zayheda Khan. “The WDA licence will significantly enhance our services within the UK and means that we can now offer a more comprehensive and streamlined solution in the country, delivering greater efficiency and tailor-made solutions for our customers”.

UK Comparator Sourcing and Logistics Services

For further information on our WDA licence and comparator sourcing and logistics services portfolio, please contact us.